Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

NCT01247597 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01247597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01247597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2011
Completion date
Not reported
Enrollment
1,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic nephroma, nasal chondromesenchymal hamartoma, ocular medulloepithelioma, ovarian sertoli-leydig cell tumors, pleuropulmonary blastoma